Suggested Dosing
Nutrition & Energy Enhancement
2.5-5 mg PO qDay-qODay
Alzheimer Disease
10-15 mg PO qDay-qODay
Parkinson Disease
10-15 mg PO qDay-qODay
Chronic Fatigue Syndrome
10-15 mg PO qDay-qODay
Suggested Uses
Chronic fatigue syndrome, improving mental clarity, alertness, and concentration, depression, jet lag, hypertension
Parkinson's disease, Alzheimer's disease
Efficacy
Insufficient information; positive results only from pilot studies or open-label studies
Dementia: Ineffective for mild to mod dementia from Alzheimer's
Adverse Effects
None reported
Warnings
Contraindications
Hypersensitivity to any component of oral product
Pregnancy & Lactation
Pregnancy Category: N/A
Lactation: N/A
Pregnancy Categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk. C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done. D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk. X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist. NA: Information not available.Pharmacology
Metabolism: N/A
Excretion: N/A
Mechanism of Action
Coenzyme involved in ATP production (glycolysis, citric acid cycle, electron transport chain)
May increase tyrosine hydroxylase-mediated dopamine production